Cyramza

Cyramza (Ramucirumab) is an intravenous medication used to treat certain types of cancer. This targeted therapy is designed to inhibit angiogenesis, the process of forming new blood vessels.

Cyramza is primarily used in combination with other cancer treatments for advanced or metastatic cancers. It is often prescribed for gastric or gastro-esophageal junction adenocarcinoma, non-small cell lung cancer, and colorectal cancer. Patients may wonder, 'What is Cyramza used for?' It is typically used to slow the progression of these cancers when they have spread to other parts of the body.

Common effects of Cyramza may include fatigue, hypertension, and diarrhea. Some patients may experience appetite loss or nausea. These effects can vary widely among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Cyramza should be administered under medical supervision due to its potent nature. Patients with a history of severe hypertension or bleeding disorders should discuss their medical history with their healthcare provider. Proper monitoring is essential during treatment.

Cyramza may interact with other medications, particularly those that affect blood pressure or blood clotting. Alcohol and certain over-the-counter drugs may also influence its effects. Always inform your healthcare provider about all medications you are taking.